vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Perella Weinberg Partners (PWP). Click either name above to swap in a different company.
Perella Weinberg Partners is the larger business by last-quarter revenue ($219.2M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 6.3%, a 51.1% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $30.5M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
IDYA vs PWP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $219.2M |
| Net Profit | $119.2M | $13.8M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 8.5% |
| Net Margin | 57.4% | 6.3% |
| Revenue YoY | — | -2.9% |
| Net Profit YoY | 330.1% | — |
| EPS (diluted) | $1.33 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $219.2M | ||
| Q3 25 | $207.8M | $164.6M | ||
| Q2 25 | — | $155.3M | ||
| Q1 25 | — | $211.8M | ||
| Q4 24 | — | $225.7M | ||
| Q3 24 | $0 | $278.2M | ||
| Q2 24 | $0 | $272.0M | ||
| Q1 24 | $0 | $102.1M |
| Q4 25 | — | $13.8M | ||
| Q3 25 | $119.2M | $6.0M | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $17.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.8M | $16.4M | ||
| Q2 24 | $-52.8M | $-66.0M | ||
| Q1 24 | $-39.6M | $-35.8M |
| Q4 25 | — | 8.5% | ||
| Q3 25 | 52.2% | 5.4% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 12.9% | ||
| Q2 24 | — | -30.2% | ||
| Q1 24 | — | -52.4% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | 57.4% | 3.6% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | -24.3% | ||
| Q1 24 | — | -35.1% |
| Q4 25 | — | $0.11 | ||
| Q3 25 | $1.33 | $0.08 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.60 | $0.24 | ||
| Q2 24 | $-0.68 | $-1.21 | ||
| Q1 24 | $-0.53 | $-0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $255.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $-127.4M |
| Total Assets | $1.2B | $797.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $255.9M | ||
| Q3 25 | $786.9M | $185.5M | ||
| Q2 25 | — | $145.0M | ||
| Q1 25 | — | $111.2M | ||
| Q4 24 | — | $407.4M | ||
| Q3 24 | $920.0M | $335.1M | ||
| Q2 24 | $701.7M | $185.3M | ||
| Q1 24 | $698.8M | $156.7M |
| Q4 25 | — | $-127.4M | ||
| Q3 25 | $1.1B | $-302.4M | ||
| Q2 25 | — | $-318.4M | ||
| Q1 25 | — | $-323.1M | ||
| Q4 24 | — | $-421.4M | ||
| Q3 24 | $1.2B | $-360.8M | ||
| Q2 24 | $931.7M | $-283.0M | ||
| Q1 24 | $935.3M | $161.9M |
| Q4 25 | — | $797.6M | ||
| Q3 25 | $1.2B | $650.2M | ||
| Q2 25 | — | $606.7M | ||
| Q1 25 | — | $570.5M | ||
| Q4 24 | — | $876.8M | ||
| Q3 24 | $1.2B | $810.9M | ||
| Q2 24 | $973.7M | $645.5M | ||
| Q1 24 | $961.5M | $583.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $34.8M |
| Free Cash FlowOCF − Capex | $142.2M | $30.5M |
| FCF MarginFCF / Revenue | 68.4% | 13.9% |
| Capex IntensityCapex / Revenue | 0.0% | 2.0% |
| Cash ConversionOCF / Net Profit | 1.19× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-34.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $34.8M | ||
| Q3 25 | $142.2M | $59.2M | ||
| Q2 25 | — | $56.1M | ||
| Q1 25 | — | $-176.5M | ||
| Q4 24 | — | $223.4M | ||
| Q3 24 | $-49.2M | $200.3M | ||
| Q2 24 | $-32.9M | $90.0M | ||
| Q1 24 | $-43.8M | $-206.3M |
| Q4 25 | — | $30.5M | ||
| Q3 25 | $142.2M | $57.6M | ||
| Q2 25 | — | $55.3M | ||
| Q1 25 | — | $-177.6M | ||
| Q4 24 | — | $207.0M | ||
| Q3 24 | $-49.7M | $199.3M | ||
| Q2 24 | $-33.9M | $83.7M | ||
| Q1 24 | $-45.1M | $-214.8M |
| Q4 25 | — | 13.9% | ||
| Q3 25 | 68.4% | 35.0% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | — | -83.8% | ||
| Q4 24 | — | 91.7% | ||
| Q3 24 | — | 71.6% | ||
| Q2 24 | — | 30.8% | ||
| Q1 24 | — | -210.3% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 8.3% |
| Q4 25 | — | 2.52× | ||
| Q3 25 | 1.19× | 9.85× | ||
| Q2 25 | — | 20.50× | ||
| Q1 25 | — | -10.18× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 12.23× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
